Maylan Laboratories Limited

Ukraine

All drugs from this manufacturer

  • ACRIPTEGA

    The drug is intended for the treatment of adults and children (weighing at least 40 kg) infected with the human immunodeficiency virus (HIV).

    Dosage form: tablets, film-coated

    Active substance Dosage
    dolutegravir 50 mg
    lamivudine 300 mg
    tenofovir disoproxil 245 mg

    ATC: J05AR27

  • DOLUTEGRAVIR

    The drug is used in combination with other antiretroviral agents for the treatment of adults and children aged 12 years and older (or children weighing at least 40 kg) infected with HIV-1.

    Dosage form: tablets, film-coated

    Active substance Dosage
    dolutegravir 50 mg

    ATC: J05AJ03

  • DOVPRELA

    The drug is intended for the treatment of adult patients with pulmonary tuberculosis that is resistant to standard treatment (resistant to isoniazid, rifampicin, fluoroquinolones, and other second-line drugs).

    Dosage form: tablets

    Active substance Dosage
    pretomanid 200 mg

    ATC: J04AK08

  • KOCITAF

    The drug is intended for the treatment of adults and children (from 12 years of age with a body weight of at least 40 kg) infected with human immunodeficiency virus type 1 (HIV-1), in combination with other antiviral agents.

    Dosage form: tablets, film-coated

    Active substance Dosage
    dolutegravir 50 mg
    emtricitabine 200 mg
    tenofovir alafenamide 25 mg

    ATC: J05AR

  • MAIDEKLA

    The drug is used in combination with other medicinal products for the treatment of chronic hepatitis C in adults.

    Dosage form: tablets, film-coated

    Active substance Dosage
    daclatasvir 60 mg

    ATC: J05AP07

  • MAYHEP

    The drug is used in combination with other medicinal products for the treatment of chronic hepatitis C in adult patients.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg

    ATC: J05AP08

  • MAYHEP ALL

    The drug is intended for the treatment of chronic hepatitis C virus (HCV) infection in adults.

    Dosage form: tablets, film-coated

    Active substance Dosage
    sofosbuvir 400 mg
    velpatasvir 100 mg

    ATC: J05AP55

  • TENOFOVIR ALAFENAMIDE

    The drug is intended for the treatment of chronic hepatitis B in adults and adolescents (aged 12 years and older weighing at least 35 kg).

    Dosage form: tablets, film-coated

    Active substance Dosage
    tenofovir alafenamide 25 mg

    ATC: J05AF13

  • ZOVILAM

    The drug is used for the treatment of HIV infection.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lamivudine 150 mg
    zidovudine 300 mg

    ATC: J05AR01